Affymax, Inc. (NASDAQ:AFFY) and InterMune Inc. (NASDAQ:ITMN) Added to Growing Stock Report's NASDAQ Gainers Watch List.

New York, NY -- (SBWIRE) -- 03/21/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Affymax, Inc. (NASDAQ:AFFY) and InterMune Inc. (NASDAQ:ITMN).

Affymax, Inc. (NASDAQ:AFFY) a biopharmaceutical company that engages in the development of drugs for the treatment of serious and life-threatening conditions in the United States is currently up (+15.88%) on 14,088,423 shares traded. Affymax, Inc. (NASDAQ:AFFY) is currently up (+55.45%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Affymax, Inc. (NASDAQ:AFFY)

InterMune Inc. (NASDAQ:ITMN) a biotechnology company that engages in the research, development, and commercialization of therapies in pulmonology and orphan fibrotic diseases is currently up (+6.56%) on 1,293,376 shares traded after InterMune said it plans to launch its lung disease treatment Esbriet in England and Wales this summer. InterMune Inc. (NASDAQ:ITMN) is currently up (+38.42%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about InterMune Inc. (NASDAQ:ITMN)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com